Teresa Briggs - 16 Jun 2026 Form 4 Insider Report for Warby Parker Inc. (WRBY)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
18 Jun 2026, 17:39:27 UTC
Prior SEC filing
10 Jun 2026
Next SEC filing
01 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Chris Utecht, Attorney-in-Fact

Key filing fact

Teresa Briggs filed Form 4 for Warby Parker Inc. (WRBY) on 18 Jun 2026.

Key facts

  • This page summarizes Teresa Briggs's Form 4 filing for Warby Parker Inc. (WRBY).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 18 Jun 2026, 17:39.

Change

  • Previous filing in this sequence was filed on 10 Jun 2026.
  • Current net transaction value: -$129,683.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001767659 Primary reporting owner

Briggs Teresa

Relationship
Director
Address
233 SPRING STREET, 6TH FLOOR EAST, NEW YORK
Signature
/s/ Chris Utecht, Attorney-in-Fact
Signature date
18 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

WRBY transaction

Class A Common Stock

Sale

Transaction value
$78,568
Shares
-3,092
Change %
-5.7%
Price
$25.41
Shares after
50,791
Date
16 Jun 2026
Ownership
Direct
Footnotes
F1, F2
WRBY transaction

Class A Common Stock

Sale

Transaction value
$51,115
Shares
-1,908
Change %
-3.8%
Price
$26.79
Shares after
48,883
Date
16 Jun 2026
Ownership
Direct
Footnotes
F1, F3
WRBY holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
15,969
Date
16 Jun 2026
Ownership
By Trust
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 4 footnotes

Footnote F1

These share sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 17, 2026.

Footnote F2

The price reported in Column 4 is an average execution price rounded to the nearest hundredth. These shares were sold in multiple transactions at prices ranging from $25.05 to $25.82 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

Footnote F3

The price reported in Column 4 is an average execution price rounded to the nearest hundredth. These shares were sold in multiple transactions at prices ranging from $26.46 to $27.06 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

Footnote F4

Ms. Briggs may be deemed to have voting power and dispositive power over the shares held by The Teresa Briggs Trust.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .